Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid Sources
1.5.1.2 Unpaid Sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 HLA typing for transplant industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Technology trends
2.2.2 Product and services trends
2.2.3 Application trends
2.2.4 End-use trends
2.2.5 Regional trends
Chapter 3 HLA Typing for Transplant Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of solid organ transplants
3.3.1.2 Technological advancements
3.3.1.3 Increasing geriatric population
3.3.2 Restraints
3.3.2.1 Significant gap between number of organs donated and organs required
3.3.2.2 High cost of molecular tests
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By product and services
3.4.3 By application
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Total number of HLA typing test performed annually, by region, 2017-2021 (000’ Units)
3.7 Pricing analysis, 2021
3.8 In-house lab-based HLA typing test v/s kits from diagnostic manufacturer
3.9 Evolution of different HLA typing method
3.9.1 PCR-based testing method
3.9.2 NGS-based testing method
3.10 Regulatory landscape
3.10.1 U.S.
3.10.2 Europe
3.11 Porter’s analysis
3.11.1 Bargaining power of buyers
3.11.2 Bargaining power of suppliers
3.11.3 Threat of new entrants
3.11.4 Threat of substitutes
3.11.5 Industry rivalry
3.12 PESTEL analysis
3.12.1 Political
3.12.1 Economic
3.12.1 Social
3.12.1 Technological
3.12.1 Environmental
3.12.2 Legal
Chapter 4 Competition Landscape, 2022
4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Company matrix analysis, 2022
4.4 Strategy dashboard, 2022
Chapter 5 HLA Typing for Transplant Market, By Technology
5.1 Key segment trends
5.2 Non-molecular assays
5.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.2 Serological assays
5.2.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.3 Mixed lymphocyte culture assays
5.2.3.1 Market size, by region, 2018-2032 (USD Million)
5.3 Molecular assays
5.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.2 PCR based molecular assays
5.3.2.1 Market size, by region, 2018-2032 (USD Million)
5.3.3 Sequencing based molecular assays
5.3.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.3.2 Sanger sequencing
5.3.3.2.1 Market size, by region, 2018-2032 (USD Million)
5.3.3.3 Next generation sequencing
5.3.3.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 6 HLA Typing for Transplant Market, By Product & Services
6.1 Key segment trends
6.2 Instruments
6.2.1 Market size, by region, 2018-2032 (USD Million)
6.3 Reagents and consumables
6.3.1 Market size, by region, 2018-2032 (USD Million)
6.4 Software
6.4.1 Market size, by region, 2018-2032 (USD Million)
6.5 Services
6.5.1 Market size, by region, 2018-2032 (USD Million)
Chapter 7 HLA Typing for Transplant Market, By Application
7.1 Key segment trends
7.2 Diagnostics
7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Research
7.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 8 HLA Typing for Transplant Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market size, by region, 2018-2032 (USD Million)
8.3 Diagnostic labs
8.3.1 Market size, by region, 2018-2032 (USD Million)
8.4 Academic and research institutes centers
8.4.1 Market size, by region, 2018-2032 (USD Million)
Chapter 9 HLA Typing for Transplant Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 Market size, by country, 2018-2032 (USD Million)
9.2.2 Market size, by technology, 2018-2032 (USD Million)
9.2.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.3 Market size, by product and services, 2018-2032 (USD Million)
9.2.4 Market size, by application, 2018-2032 (USD Million)
9.2.5 Market size, by end-use, 2018-2032 (USD Million)
9.2.6 U.S.
9.2.6.1 Market size, by technology, 2018-2032 (USD Million)
9.2.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.2.6.3 Market size, by application, 2018-2032 (USD Million)
9.2.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.2.7 Canada
9.2.7.1 Market size, by technology, 2018-2032 (USD Million)
9.2.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.2.7.3 Market size, by application, 2018-2032 (USD Million)
9.2.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.3 Europe
9.3.1 Market size, by country, 2018-2032 (USD Million)
9.3.2 Market size, by technology, 2018-2032 (USD Million)
9.3.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.3 Market size, by product and services, 2018-2032 (USD Million)
9.3.4 Market size, by application, 2018-2032 (USD Million)
9.3.5 Market size, by end-use, 2018-2032 (USD Million)
9.3.6 Germany
9.3.6.1 Market size, by technology, 2018-2032 (USD Million)
9.3.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.6.3 Market size, by application, 2018-2032 (USD Million)
9.3.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.7 UK
9.3.7.1 Market size, by technology, 2018-2032 (USD Million)
9.3.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.7.3 Market size, by application, 2018-2032 (USD Million)
9.3.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.8 France
9.3.8.1 Market size, by technology, 2018-2032 (USD Million)
9.3.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.8.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.8.3 Market size, by application, 2018-2032 (USD Million)
9.3.8.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.9 Italy
9.3.9.1 Market size, by technology, 2018-2032 (USD Million)
9.3.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.9.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.9.3 Market size, by application, 2018-2032 (USD Million)
9.3.9.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.10 Spain
9.3.10.1 Market size, by technology, 2018-2032 (USD Million)
9.3.10.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.10.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.10.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.10.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.10.3 Market size, by application, 2018-2032 (USD Million)
9.3.10.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.11 Russia
9.3.11.1 Market size, by technology, 2018-2032 (USD Million)
9.3.11.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.11.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.11.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.11.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.11.3 Market size, by application, 2018-2032 (USD Million)
9.3.11.4 Market size, by end-use, 2018-2032 (USD Million)
9.4 Asia Pacific
9.4.1 Market size, by country, 2018-2032 (USD Million)
9.4.2 Market size, by technology, 2018-2032 (USD Million)
9.4.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.3 Market size, by product and services, 2018-2032 (USD Million)
9.4.4 Market size, by application, 2018-2032 (USD Million)
9.4.5 Market size, by end-use, 2018-2032 (USD Million)
9.4.6 China
9.4.6.1 Market size, by technology, 2018-2032 (USD Million)
9.4.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.6.3 Market size, by application, 2018-2032 (USD Million)
9.4.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.7 India
9.4.7.1 Market size, by technology, 2018-2032 (USD Million)
9.4.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.7.3 Market size, by application, 2018-2032 (USD Million)
9.4.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.8 Japan
9.4.8.1 Market size, by technology, 2018-2032 (USD Million)
9.4.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.8.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.8.3 Market size, by application, 2018-2032 (USD Million)
9.4.8.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.9 Australia
9.4.9.1 Market size, by technology, 2018-2032 (USD Million)
9.4.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.9.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.9.3 Market size, by application, 2018-2032 (USD Million)
9.4.9.4 Market size, by end-use, 2018-2032 (USD Million)
9.5 Latin America
9.5.1 Market size, by country, 2018-2032 (USD Million)
9.5.2 Market size, by technology, 2018-2032 (USD Million)
9.5.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.3 Market size, by product and services, 2018-2032 (USD Million)
9.5.4 Market size, by application, 2018-2032 (USD Million)
9.5.5 Market size, by end-use, 2018-2032 (USD Million)
9.5.6 Brazil
9.5.6.1 Market size, by technology, 2018-2032 (USD Million)
9.5.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.5.6.3 Market size, by application, 2018-2032 (USD Million)
9.5.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.5.7 Mexico
9.5.7.1 Market size, by technology, 2018-2032 (USD Million)
9.5.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.5.7.3 Market size, by application, 2018-2032 (USD Million)
9.5.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.6 MEA
9.6.1 Market size, by country, 2018-2032 (USD Million)
9.6.2 Market size, by technology, 2018-2032 (USD Million)
9.6.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.3 Market size, by product and services, 2018-2032 (USD Million)
9.6.4 Market size, by application, 2018-2032 (USD Million)
9.6.5 Market size, by end-use, 2018-2032 (USD Million)
9.6.6 South Africa
9.6.6.1 Market size, by technology, 2018-2032 (USD Million)
9.6.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.6.6.3 Market size, by application, 2018-2032 (USD Million)
9.6.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.6.7 Saudi Arabia
9.6.7.1 Market size, by technology, 2018-2032 (USD Million)
9.6.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.6.7.3 Market size, by application, 2018-2032 (USD Million)
9.6.7.4 Market size, by end-use, 2018-2032 (USD Million)
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Product landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 Bio-Rad Laboratories
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 BioReference Laboratories
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 SWOT analysis
10.4 CareDx, Inc.
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 GenDx
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Illumina Inc.
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 Immucor Inc.
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 Inno-train Diagnostik GmbH
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 SWOT analysis
10.9 Luminex Corporation
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 SWOT analysis
10.10 Omixon, Inc
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 Pacific Biosciences of California, Inc
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Qiagen N.V.
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 SWOT analysis
10.13 F. Hoffmann-La Roche Ltd
10.13.1 Business overview
10.13.2 Financial data
10.13.3 Product landscape
10.13.4 SWOT analysis
10.14 Thermo-Fisher Scientific Inc.
10.14.1 Business overview
10.14.2 Financial data
10.14.3 Product landscape
10.14.4 Strategic outlook
10.14.5 SWOT analysis
10.15 Fujirebio
10.15.1 Business overview
10.15.2 Financial data
10.15.3 Product landscape
10.15.4 SWOT analysis
10.16 BAG Diagnostic GmbH
10.16.1 Business overview
10.16.2 Financial data
10.16.3 Product landscape
10.16.4 SWOT analysis
10.17 GMSbiotech, Inc.
10.17.1 Business overview
10.17.2 Financial data
10.17.3 Product landscape
10.17.4 SWOT analysis
10.18 Biofortuna Limited
10.18.1 Business overview
10.18.2 Financial data
10.18.3 Product landscape
10.18.4 Strategic outlook
10.18.5 SWOT analysis
10.19 TBG Diagnostics Limited
10.19.1 Business overview
10.19.2 Financial data
10.19.3 Product landscape
10.19.4 Strategic outlook
10.19.5 SWOT analysis

Data Tables
TABLE 1. Global HLA typing for transplant market, 2018 - 2022 (USD Million)
TABLE 2. Global HLA typing for transplant market, 2023 - 2032 (USD Million)
TABLE 3. Global HLA typing for transplant market, by technology, 2018 - 2022 (USD Million)
TABLE 4. Global HLA typing for transplant market, by technology, 2023 - 2032 (USD Million)
TABLE 5. Global HLA typing for transplant market, by product and services, 2018 - 2022 (USD Million)
TABLE 6. Global HLA typing for transplant market, by product and services, 2023 - 2032 (USD Million)
TABLE 7. Global HLA typing for transplant market, by application, 2018 - 2022 (USD Million)
TABLE 8. Global HLA typing for transplant market, by application, 2023 - 2032 (USD Million)
TABLE 9. Global HLA typing for transplant market, by end-use, 2018 - 2022 (USD Million)
TABLE 10. Global HLA typing for transplant market, by end-use, 2023 - 2032 (USD Million)
TABLE 11. Global HLA typing for transplant market, by region, 2018 - 2022 (USD Million)
TABLE 12. Global HLA typing for transplant market, by region, 2023 - 2032 (USD Million)
TABLE 13. Industry impact forces
TABLE 14. Total number of HLA typing test performed annually, by region, 2017-2021 (000’ Units)
TABLE 15. Global HLA typing average test price, 2021 (USD)
TABLE 16. Comparison between in-house lab-based HLA typing test and commercially available test kits
TABLE 17. Non-molecular assays market, by region, 2018 - 2022, (USD Million)
TABLE 18. Non-molecular assays market, by region, 2023 - 2032, (USD Million)
TABLE 19. Serological assays market, by region, 2018 - 2022, (USD Million)
TABLE 20. Serological assays market, by region, 2023-2032, (USD Million)
TABLE 21. Mixed lymphocyte culture assays market, by region, 2018 - 2022, (USD Million)
TABLE 22. Mixed lymphocyte culture assays market, by region, 2023-2032, (USD Million)
TABLE 23. Molecular assays market, by region, 2018 - 2022, (USD Million)
TABLE 24. Molecular assays market, by region, 2023-2032, (USD Million)
TABLE 25. PCR based molecular assays market, by region, 2018 - 2022, (USD Million)
TABLE 26. PCR based molecular assays market, by region, 2023-2032, (USD Million)
TABLE 27. Sequencing based molecular assays market, by region, 2018 - 2022, (USD Million)
TABLE 28. Sequencing based molecular assays market, by region, 2023-2032, (USD Million)
TABLE 29. Sanger sequencing market, by region, 2018 - 2022, (USD Million)
TABLE 30. Sanger sequencing market, by region, 2023-2032, (USD Million)
TABLE 31. Next generation sequencing market, by region, 2018 - 2022, (USD Million)
TABLE 32. Next generation sequencing market, by region, 2023-2032, (USD Million)
TABLE 33. Instruments market, by region, 2018 - 2022, (USD Million)
TABLE 34. Instruments market, by region, 2023-2032, (USD Million)
TABLE 35. Reagents and consumables market, by region, 2018 - 2022, (USD Million)
TABLE 36. Reagents and consumables market, by region, 2023-2032, (USD Million)
TABLE 37. Software market, by region, 2018 - 2022, (USD Million)
TABLE 38. Software market, by region, 2023-2032, (USD Million)
TABLE 39. Services market, by region, 2018 - 2022, (USD Million)
TABLE 40. Services market, by region, 2023-2032, (USD Million)
TABLE 41. Diagnostics market, by region, 2018 - 2022, (USD Million)
TABLE 42. Diagnostics market, by region, 2023-2032, (USD Million)
TABLE 43. Research market, by region, 2018 - 2022, (USD Million)
TABLE 44. Research market, by region, 2023-2032, (USD Million)
TABLE 45. Hospitals market, by region, 2018 - 2022, (USD Million)
TABLE 46. Hospitals market, by region, 2023-2032, (USD Million)
TABLE 47. Diagnostic labs market, by region, 2018 - 2022, (USD Million)
TABLE 48. Diagnostic labs market, by region, 2023-2032, (USD Million)
TABLE 49. Academic and research institutes centers market, by region, 2018 - 2022, (USD Million)
TABLE 50. Academic and research institutes centers market, by region, 2023-2032, (USD Million)
TABLE 51. North America HLA typing for transplant market, by country, 2018-2022, (USD Million)
TABLE 52. North America HLA typing for transplant market, by country, 2023-2032, (USD Million)
TABLE 53. North America HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 54. North America HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 55. North America HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 56. North America HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 57. North America HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 58. North America HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 59. North America HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 60. North America HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 61. North America HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 62. North America HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 63. North America HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 64. North America HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 65. North America HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 66. North America HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 67. U.S. HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 68. U.S. HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 69. U.S. HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 70. U.S. HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 71. U.S. HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 72. U.S. HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 73. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 74. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 75. U.S. HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 76. U.S. HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 77. U.S. HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 78. U.S. HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 79. U.S. HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 80. U.S. HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 81. Canada HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 82. Canada HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 83. Canada HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 84. Canada HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 85. Canada HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 86. Canada HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 87. Canada HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 88. Canada HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 89. Canada HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 90. Canada HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 91. Canada HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 92. Canada HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 93. Canada HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 94. Canada HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 95. Europe HLA typing for transplant market, by country, 2018-2022, (USD Million)
TABLE 96. Europe HLA typing for transplant market, by country, 2023-2032, (USD Million)
TABLE 97. Europe HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 98. Europe HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 99. Europe HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 100. Europe HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)<

List of Tables

TABLE 131. UK HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 132. UK HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 133. UK HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 134. UK HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 135. UK HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 136. UK HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 137. UK HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 138. UK HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 139. France HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 140. France HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 141. France HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 142. France HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 143. France HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 144. France HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 145. France HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 146. France HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 147. France HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 148. France HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 149. France HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 150. France HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 151. France HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 152. France HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 153. Italy HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 154. Italy HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 155. Italy HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 156. Italy HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 157. Italy HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 158. Italy HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 159. Italy HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 160. Italy HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 161. Italy HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 162. Italy HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 163. Italy HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 164. Italy HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 165. Italy HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 166. Italy HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 167. Spain HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 168. Spain HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 169. Spain HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 170. Spain HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 171. Spain HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 172. Spain HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 173. Spain HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 174. Spain HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 175. Spain HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 176. Spain HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 177. Spain HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 178. Spain HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 179. Spain HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 180. Spain HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 181. Russia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 182. Russia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 183. Russia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 184. Russia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 185. Russia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 186. Russia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 187. Russia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 188. Russia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 189. Russia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 190. Russia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 191. Russia HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 192. Russia HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 193. Russia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 194. Russia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 195. Asia Pacific HLA typing for transplant market, by country, 2018-2022, (USD Million)
TABLE 196. Asia Pacific HLA typing for transplant market, by country, 2023-2032, (USD Million)
TABLE 197. Asia Pacific HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 198. Asia Pacific HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 199. Asia Pacific HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 200. Asia Pacific HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 201. Asia Pacific HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 202. Asia Pacific HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 203. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 204. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 205. Asia Pacific HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 206. Asia Pacific HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 207. Asia Pacific HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 208. Asia Pacific HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 209. Asia Pacific HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 210. Asia Pacific HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 211. China HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 212. China HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 213. China HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 214. China HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 215. China HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 216. China HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 217. China HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 218. China HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 219. China HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 220. China HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 221. China HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 222. China HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 223. China HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 224. China HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 225. India HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 226. India HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 227. India HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 228. India HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 229. India HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 230. India HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 231. India HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 232. India HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 233. India HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 234. India HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 235. India HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 236. India HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 237. India HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 238. India HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 239. Japan HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 240. Japan HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 241. Japan HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 242. Japan HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 243. Japan HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 244. Japan HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 245. Japan HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 246. Japan HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 247. Japan HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 248. Japan HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 249. Japan HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 250. Japan HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 251. Japan HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 252. Japan HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 253. Australia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 254. Australia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 255. Australia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 256. Australia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 257. Australia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 258. Australia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 259. Australia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 260. Australia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 261. Australia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 262. Australia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 263. Australia HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 264. Australia HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 265. Australia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 266. Australia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 267. Latin America HLA typing for transplant market, by country, 2018-2022, (USD Million)
TABLE 268. Latin America HLA typing for transplant market, by country, 2023-2032, (USD Million)
TABLE 269. Latin America HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 270. Latin America HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 271. Latin America HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 272. Latin America HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 273. Latin America HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 274. Latin America HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 275. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 276. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 277. Latin America HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 278. Latin America HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 279. Latin America HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 280. Latin America HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 281. Latin America HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 282. Latin America HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 283. Brazil HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 284. Brazil HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 285. Brazil HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 286. Brazil HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 287. Brazil HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 288. Brazil HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 289. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 290. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 291. Brazil HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 292. Brazil HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 293. Brazil HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 294. Brazil HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 295. Brazil HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 296. Brazil HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 297. Mexico HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 298. Mexico HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 299. Mexico HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 300. Mexico HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 301. Mexico HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 302. Mexico HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 303. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 304. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 305. Mexico HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 306. Mexico HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 307. Mexico HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 308. Mexico HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 309. Mexico HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 310. Mexico HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 311. MEA HLA typing for transplant market, by country, 2018-2022, (USD Million)
TABLE 312. MEA HLA typing for transplant market, by country, 2023-2032, (USD Million)
TABLE 313. MEA HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 314. MEA HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 315. MEA HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 316. MEA HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 317. MEA HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 318. MEA HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 319. MEA HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 320. MEA HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 321. MEA HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 322. MEA HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 323. MEA HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 324. MEA HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 325. MEA HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 326. MEA HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 327. South Africa HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 328. South Africa HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 329. South Africa HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 330. South Africa HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 331. South Africa HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 332. South Africa HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 333. South Africa HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 334. South Africa HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 335. South Africa HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 336. South Africa HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 337. South Africa HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 338. South Africa HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 339. South Africa HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 340. South Africa HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
TABLE 341. Saudi Arabia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
TABLE 342. Saudi Arabia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
TABLE 343. Saudi Arabia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
TABLE 344. Saudi Arabia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
TABLE 345. Saudi Arabia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
TABLE 346. Saudi Arabia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
TABLE 347. Saudi Arabia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
TABLE 348. Saudi Arabia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
TABLE 349. Saudi Arabia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
TABLE 350. Saudi Arabia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
TABLE 351. Saudi Arabia HLA typing for transplant market, by application, 2018-2022, (USD Million)
TABLE 352. Saudi Arabia HLA typing for transplant market, by application, 2023-2032, (USD Million)
TABLE 353. Saudi Arabia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
TABLE 354. Saudi Arabia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)

Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 HLA typing for transplant industry 360 degree synopsis, 2018 - 2032
FIG. 4 Industry segmentation
FIG. 5 Industry landscape, 2018-2032 (USD Million)
FIG. 6 U.S. transplantation, by organ, 2021
FIG. 7 Proportion for various organs for which patients were on the waiting list in the U.S. (2021)
FIG. 8 Growth potential analysis, by technology
FIG. 9 Growth potential analysis, by product and services
FIG. 10 Growth potential analysis, by application
FIG. 11 Growth potential analysis, by end-use
FIG. 12 Company market share analysis, 2022
FIG. 13 Company matrix analysis, 2022
FIG. 14 Strategy dashboard, 2022
FIG. 15 Key segment trends, by technology
FIG. 16 Key segment trends, by product & services
FIG. 17 Key segment trends, by application
FIG. 18 Key segment trends, by end-use
FIG. 19 Key regional trends